Chemotherapeutic and tooth disorder 
Chemotherapeutic and tooth disorder Patient Reports February 11, 2012
Chemotherapeutic Side Effects Report #4955500-2
Chemotherapeutic side effect was reported by a Consumer or non-health professional from DENMARK on Dec 15, 2004. Male patient, 76 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: abscess jaw, bone disorder, fistula , osteonecrosis , pain in jaw, tooth disorder . Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA, PREDNISONE, ALKERAN, THALIDOMID. Patient recovered.Chemotherapeutic Side Effects Report #4970651-4
Chemotherapeutic side effect was reported by a Consumer or non-health professional from DENMARK on Dec 15, 2004. Male patient, 76 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: abscess jaw, bone disorder, fistula , osteonecrosis , pain in jaw, sequestrectomy, tooth disorder . Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA, PREDNISONE, ALKERAN, THALIDOMID. Patient recovered.Chemotherapeutic Side Effects Report #5017826-6
Chemotherapeutic side effect was reported by a Consumer or non-health professional from DENMARK on Dec 15, 2004. Male patient, 76 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: abscess jaw, bone disorder, fistula , osteonecrosis , pain in jaw, sequestrectomy, tooth disorder . Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA, PREDNISONE, ALKERAN, THALIDOMID. Patient recovered.Chemotherapeutic Side Effects Report #4668893-0
Chemotherapeutic side effect was reported by a Consumer or non-health professional from on Apr 23, 2004. Female patient, 60 years of age, was diagnosed with metastases to bone and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: aseptic necrosis bone, osteomyelitis, pain in jaw, pyrexia, tooth disorder
, wound debridement. Chemotherapeutic dosage: unknown. During the same period patient was treated with HORMONES AND RELATED AGENTS, ZOMETA. Patient recovered.